Document is current
Any future updates will be listed below
-
Authors
Rehnström, Mimmi
Frederiksen, Simona Denise
Ansar, Saema
Edvinsson, Lars http://orcid.org/0000-0002-1805-1346
-
Funding
Funding for this research was provided by:
Knut och Alice Wallenbergs Stiftelse
Hjärt-Lungfonden
Vetenskapsrådet (5958)
- License Information
-
More Information
Article History
Received: 4 September 2020
Accepted: 28 November 2020
First Online: 9 December 2020
Ethics approval and consent to participate
: All experiments and procedures were performed in accordance with guidelines for the European Community Council Directive (2010/63/EU) for Protection of Vertebrate Animals Used for Experimental and other Scientific Purposes. The experimental procedures were approved by Lund-Malmö Institutional Ethics Committee under the auspices of the Swedish National Department of Agriculture (ethical permit number M153–15). The study complies with the ARRIVE guidelines (Animal Research: Reporting in Vivo Experiments).
: Not applicable.
: LE is the CSO and founder of the Edvince research company which aims at developing and commercializing new methods for acute treatment of stroke. However, this did not affect the outcomes of the study. The other authors declare that they have no competing interests.
